国产午夜福利片1000无码丨人妻国产成人久久av免费高清丨午夜做受视频试看6次丨日韩av不卡一区在线免费观看丨在线观看精品三级欧美

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Shewanella putrefaciens Ribosome maturation factor RimP (rimP) CSB-YP397816STQ
CSB-EP397816STQ
CSB-BP397816STQ
CSB-MP397816STQ
CSB-EP397816STQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella putrefaciens (Dimethylallyl)adenosine tRNA methylthiotransferase MiaB CSB-YP397817STQ
CSB-EP397817STQ
CSB-BP397817STQ
CSB-MP397817STQ
CSB-EP397817STQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella putrefaciens Ribosomal RNA large subunit methyltransferase I (rlmI) CSB-YP397818STQ
CSB-EP397818STQ
CSB-BP397818STQ
CSB-MP397818STQ
CSB-EP397818STQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella putrefaciens Protein slyX homolog (slyX) CSB-YP397819STQ
CSB-EP397819STQ
CSB-BP397819STQ
CSB-MP397819STQ
CSB-EP397819STQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella putrefaciens Sulfite reductase [NADPH] hemoprotein beta-component (cysI), partial CSB-YP397820STQ
CSB-EP397820STQ
CSB-BP397820STQ
CSB-MP397820STQ
CSB-EP397820STQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella putrefaciens Ribosomal RNA small subunit methyltransferase C (rsmC) CSB-YP397821STQ
CSB-EP397821STQ
CSB-BP397821STQ
CSB-MP397821STQ
CSB-EP397821STQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella putrefaciens RNA polymerase-associated protein RapA (rapA), partial CSB-YP397822STQ
CSB-EP397822STQ
CSB-BP397822STQ
CSB-MP397822STQ
CSB-EP397822STQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella putrefaciens Large-conductance mechanosensitive channel (mscL), partial CSB-YP397823STQ1
CSB-EP397823STQ1
CSB-BP397823STQ1
CSB-MP397823STQ1
CSB-EP397823STQ1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella putrefaciens DNA-binding protein fis (fis) CSB-YP397824STQ
CSB-EP397824STQ
CSB-BP397824STQ
CSB-MP397824STQ
CSB-EP397824STQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella putrefaciens UPF0061 protein Sputcn32_3659 (Sputcn32_3659) CSB-YP397825STQ
CSB-EP397825STQ
CSB-BP397825STQ
CSB-MP397825STQ
CSB-EP397825STQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella putrefaciens 50S ribosomal protein L6 (rplF) CSB-YP397826STQ
CSB-EP397826STQ
CSB-BP397826STQ
CSB-MP397826STQ
CSB-EP397826STQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella putrefaciens 50S ribosomal protein L29 (rpmC) CSB-YP397827STQ
CSB-EP397827STQ
CSB-BP397827STQ
CSB-MP397827STQ
CSB-EP397827STQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella putrefaciens 50S ribosomal protein L3 (rplC) CSB-YP397828STQ
CSB-EP397828STQ
CSB-BP397828STQ
CSB-MP397828STQ
CSB-EP397828STQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella putrefaciens Ribonuclease P protein component (rnpA) CSB-YP397829STQ
CSB-EP397829STQ
CSB-BP397829STQ
CSB-MP397829STQ
CSB-EP397829STQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Metallosphaera sedula 50S ribosomal protein L2P (rpl2p) CSB-YP397830MNM
CSB-EP397830MNM
CSB-BP397830MNM
CSB-MP397830MNM
CSB-EP397830MNM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Metallosphaera sedula 50S ribosomal protein L18P (rpl18p) CSB-YP397831MNM
CSB-EP397831MNM
CSB-BP397831MNM
CSB-MP397831MNM
CSB-EP397831MNM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Metallosphaera sedula Leucine--tRNA ligase 1 (leuS1), partial CSB-YP397832MNM
CSB-EP397832MNM
CSB-BP397832MNM
CSB-MP397832MNM
CSB-EP397832MNM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Metallosphaera sedula Translation initiation factor 1A (eIF1A) CSB-YP397833MNM
CSB-EP397833MNM
CSB-BP397833MNM
CSB-MP397833MNM
CSB-EP397833MNM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Metallosphaera sedula 3-isopropylmalate dehydratase small subunit (leuD) CSB-YP397834MNM
CSB-EP397834MNM
CSB-BP397834MNM
CSB-MP397834MNM
CSB-EP397834MNM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Metallosphaera sedula Threonine--tRNA ligase (thrS), partial CSB-YP397835MNM
CSB-EP397835MNM
CSB-BP397835MNM
CSB-MP397835MNM
CSB-EP397835MNM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時,你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.jhhuazhong.com/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>